CareOsis Cefodosis-CV 325
CareOsis Cefodosis-CV 325 (Cefpodoxime Proxetil & Potassium Clavulanate Tablets): enhanced oral power against resistant infections.
A third-generation cephalosporin combined with a beta-lactamase inhibitor for reliable efficacy in recurrent and refractory infections, including resistant respiratory tract infections, community acquired pneumonia and complicated UTIs.
Quality assured
30-day return
Secure checkout
Pan India delivery
Complete product profile
Everything you need
Everything you need
to know before you decide
Key Features
- Third-generation cephalosporin for broad-spectrum coverage
- Clavulanate inhibits beta-lactamase resistance
- Reliable efficacy in recurrent & refractory infections
- Improved treatment success in resistant cases
- Excellent tolerability & better patient compliance
Health Benefits
- Effective against beta-lactamase producing strains
- Reduces risk of therapeutic failure
- Supports recovery in recurrent ENT & respiratory infections
Directions for Use
1
Dosage
As directed by the physician.
2
Complete the course
Complete the full antibiotic course as prescribed, even if symptoms improve earlier.
Important Note:
This is a prescription medicine. To be sold by retail only on the prescription of a Registered Medical Practitioner. Do not self-medicate. Use strictly as directed and complete the full course as prescribed; consult your doctor regarding interactions, contraindications, and side effects.
Every ingredient
has a purpose
Cefpodoxime Proxetil
Inhibits bacterial cell wall synthesis.
Potassium Clavulanate
Blocks the beta-lactamase enzyme, restoring antibiotic potency against resistant pathogens.
| Common Name | Concentration |
|---|---|
| Cefpodoxime Proxetil | 200 mg |
| Potassium Clavulanate | 125 mg |
Quality assurance
Certified by those
Certified by those
who hold us accountable
WHO-GMP Certified
Manufactured at a WHO-GMP certified facility, meeting international standards for quality, safety and consistency.